Llama power: can tiny llama nanobodies improve norovirus anti-viral therapies?
Llama nanobodies may offer an option for treating norovirus, a global health problem for which there are no vaccines or antiviral drugs.
Read MoreLlama nanobodies may offer an option for treating norovirus, a global health problem for which there are no vaccines or antiviral drugs.
Read MoreThe findings provide insight into the viral infection process, highlighting unique pathways and targets for developing effective therapeutics.
Read MoreThe findings are big step toward developing targeted treatments and vaccines against noroviruses attacking the gastrointestinal tract.
Read MoreDuring 2020, research news on COVID-19 led the headlines, but significant contributions emerged in other fields as well.
Read MoreFrom the Labs interviewed Victoria Tenge to learn about her experience as a graduate student at Baylor College of Medicine. She shared her love for
Read MoreSome people call it the cruise ship virus, but norovirus can be found in many other places. People can catch this very contagious virus from
Read MoreThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells and, although they comprise only a small population of the total cells, they
Read MoreDrs. Mary K. Estes, Bert O’Malley and Huda Zoghbi of Baylor College of Medicine were three of the 148 renowned academic inventors named fellows of
Read MoreWhen rotavirus infects and damages intestinal cells, the small intestine fails to absorb nutrients and diarrhea develops. Rotaviruses and noroviruses are the major cause of
Read MoreThe five winners of this year’s Michael E. DeBakey M.D. Award for Research Excellence exemplify the breadth and depth of scientific research at Baylor College
Read More